Literature DB >> 1904379

Acute intestinal injury induced by acetic acid and casein: prevention by intraluminal misoprostol.

M J Miller1, X J Zhang, X A Gu, D A Clark.   

Abstract

Acute injury was established in anesthetized rabbits by intraluminal administration of acetic acid with and without bovine casein, into loops of distal small intestine. Damage was quantified after 45 minutes by the blood-to-lumen movement of 51Cr-labeled ethylenediaminetetraacetic acid (EDTA) and fluorescein isothiocyanate-tagged bovine serum albumin as well as luminal fluid histamine levels. The amount of titratable acetic acid used to lower the pH of the treatment solutions to pH 4.0 was increased by the addition of calcium gluconate. Luminal acetic acid caused a 19-fold increase in 51Cr-EDTA accumulation over saline controls; casein did not modify this effect. In saline controls, loop fluid histamine levels bordered on the limits of detection (1 ng/g) but were elevated 19-fold by acetic acid exposure and markedly increased (118-fold) by the combination of acid and casein. Intraluminal misoprostol (3 or 30 micrograms/mL), administered 30 minutes before acetic acid, significantly attenuated the increase in epithelial permeability (luminal 51Cr-EDTA, fluorescein isothiocyanate-bovine serum albumin accumulation) and histamine release (P less than 0.05). Diphenhydramine, alone or in combination with cimetidine, and indomethacin (5 mg/kg IV) were not protective. It is concluded that exposure of the epithelium to acetic acid promotes the transepithelial movement of casein leading to enhanced mast cell activation and mucosal injury. Damage to the epithelial barrier can be prevented by misoprostol.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1904379     DOI: 10.1016/0016-5085(91)90455-t

Source DB:  PubMed          Journal:  Gastroenterology        ISSN: 0016-5085            Impact factor:   22.682


  7 in total

1.  Sulphydryl blocker induced small intestinal inflammation in rats: a new model mimicking Crohn's disease.

Authors:  D Rachmilewitz; E Okon; F Karmeli
Journal:  Gut       Date:  1997-09       Impact factor: 23.059

2.  Antibodies and antisense oligodeoxynucleotides to mu-opioid receptors, selectively block the effects of mu-opioid agonists on intestinal transit and permeability in mice.

Authors:  O Pol; L Valle; P Sánchez-Blázquez; J Garzón; M M Puig
Journal:  Br J Pharmacol       Date:  1999-05       Impact factor: 8.739

3.  Short term effects of indomethacin on rat small intestinal permeability. Role of eicosanoids and platelet activating factor.

Authors:  F Mion; J C Cuber; Y Minaire; J A Chayvialle
Journal:  Gut       Date:  1994-04       Impact factor: 23.059

4.  Mucosal protective activity of prostaglandin analogs in rodent colonic inflammation.

Authors:  D J Fretland; D L Widomski; C P Anglin; R E Walsh; S Levin; A F Gasiecki; P W Collins
Journal:  Inflammation       Date:  1992-12       Impact factor: 4.092

5.  Misoprostol attenuates acetic acid-induced damage in rabbit distal small intestine.

Authors:  M J Miller; X J Zhang; X Gu; H Sadowska-Krowicka; D A Clark
Journal:  Agents Actions       Date:  1991-09

6.  Feeding associated neonatal necrotizing enterocolitis (Primary NEC) is an inflammatory bowel disease.

Authors:  David A Clark; Upender K Munshi
Journal:  Pathophysiology       Date:  2014-01-06

7.  Anti-inflammatory agents and substance P depletion in experimental ileitis.

Authors:  M J Miller; H Sadowska-Krowicka; S Chotinaruemol; M Wong; D A Clark; A Y Jeng
Journal:  Mediators Inflamm       Date:  1993       Impact factor: 4.711

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.